Matthew J A Wood Selected Research

Matthew J A Wood Research Topics

Disease

47	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2023 - 11/2008
13	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 11/2023 - 06/2012
12	Neuromuscular Diseases (Neuromuscular Disease) 01/2023 - 04/2010
8	Inborn Genetic Diseases (Disease, Hereditary) 11/2023 - 04/2010
7	Neoplasms (Cancer) 12/2023 - 10/2012
7	Muscular Dystrophies (Muscular Dystrophy) 01/2023 - 12/2008
7	Inflammation (Inflammations) 01/2023 - 04/2011
6	Muscular Diseases (Myopathy) 11/2023 - 10/2010
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 04/2009
5	Myotonic Dystrophy (Dystrophia Myotonica) 01/2023 - 07/2012
5	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021 - 09/2009
5	Parkinson Disease (Parkinson's Disease) 01/2020 - 06/2011
4	Disease Progression 11/2023 - 11/2013
4	Muscular Atrophy (Muscle Atrophy) 01/2023 - 10/2018
4	Cardiomyopathies (Cardiomyopathy) 05/2015 - 02/2011
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 04/2011
2	Atrophy 01/2023 - 01/2022
2	Muscle Weakness 01/2022 - 03/2015
2	Hypertrophy 01/2022 - 02/2014
2	Necrosis 01/2021 - 05/2015
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 01/2018
2	Glioma (Gliomas) 10/2013 - 06/2010
2	Schizophrenia (Dementia Praecox) 01/2011 - 06/2010
1	Starvation 12/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Ulcerative Colitis 01/2023
1	Colitis 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Huntington Disease (Huntington's Disease) 11/2021
1	Neuroinflammatory Diseases 01/2021
1	Wasting Syndrome (Wasting Disease) 01/2021
1	Epilepsy (Aura) 01/2021
1	X-Linked Bulbo-Spinal Atrophy 01/2021

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 11/2023 - 08/2008
23	DystrophinIBA 12/2022 - 12/2008
17	Antisense OligonucleotidesIBA 01/2023 - 12/2008
16	OligonucleotidesIBA 01/2023 - 11/2008
12	MicroRNAs (MicroRNA)IBA 01/2023 - 04/2009
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2009
9	Peptides (Polypeptides)IBA 01/2023 - 01/2012
9	MorpholinosIBA 06/2017 - 12/2008
8	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2008
7	polyglutamineIBA 01/2022 - 09/2009
6	Cell-Penetrating PeptidesIBA 01/2023 - 07/2011
5	Small Interfering RNA (siRNA)IBA 05/2023 - 04/2011
5	Messenger RNA (mRNA)IBA 01/2021 - 04/2010
4	Glucose (Dextrose)FDA LinkGeneric 06/2023 - 03/2013
4	CytokinesIBA 01/2023 - 11/2011
4	SynucleinsIBA 01/2020 - 11/2011
3	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2021
3	alpha-SynucleinIBA 11/2017 - 04/2011
2	CalciumIBA 01/2023 - 05/2015
2	EnzymesIBA 01/2023 - 01/2011
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2019
2	nusinersenIBA 01/2021 - 10/2017
2	Nonsense Codon (Nonsense Mutation)IBA 01/2021 - 03/2015
2	3' Untranslated Regions (3' UTR)IBA 12/2020 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 07/2015 - 03/2015
2	RNA Precursors (Precursor, mRNA)IBA 01/2015 - 06/2012
2	eteplirsenIBA 08/2011 - 10/2009
1	Glutathione (Reduced Glutathione)IBA 12/2023
1	Therapeutic UsesIBA 12/2023
1	Metal-Organic FrameworksIBA 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	ProdrugsIBA 12/2023
1	GoldIBA 12/2023
1	Prednisolone (Predate)FDA LinkGeneric 11/2023
1	Glucose OxidaseIBA 06/2023
1	Glycoside Hydrolases (Endoglycosidases)IBA 06/2023
1	Hyaluronic Acid (Hyaluronan)IBA 06/2023
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2023
1	GlycogenIBA 06/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023
1	Hemin (Panhematin)FDA Link 06/2023
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Peptide Elongation Factors (Elongation Factor)IBA 01/2023
1	SuspensionsIBA 01/2023
1	Peptide Elongation Factor 2 (EF-2)IBA 01/2023
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022
1	ChromatinIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	AcidsIBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	CyclinsIBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 12/2020

Therapy/Procedure

37	Therapeutics 12/2023 - 04/2009
2	Drug Therapy (Chemotherapy) 12/2023 - 01/2023
2	Denervation 01/2022 - 01/2022
2	Investigational Therapies (Experimental Therapy) 11/2015 - 01/2014
1	Intravenous Injections 01/2023
1	Biological Therapy 01/2023
1	Oral Administration 01/2023